Business
Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report
PALO ALTO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating
About this update from Scilex Holding Company
[{"type":"text","content":"PALO ALTO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced the release of its inaugural sustainability report which highlights sustainability efforts by the company related to its environmental footprint, contributing positively to society, and improving access to medicine within the communities it serves. The Sustainability Report outlines, among other things: Environmental Stewardship: The health of our global environment impacts everyone. The Report affirms the Company’s commitment to reducing its environmental footprint.Development Excellence: The Company is dedicated to improving the lives of patients by discovering, developing and commercializing innovative non-opioid pain management medicines that address significant unmet medical needs.Social Orientation to Reinforce a Promising Future: The Company is committed to conducting business in an ethical and responsible manner. This includes respecting internationally recognized employee rights throughout its organization as well as its diverse global supply chain of numerous local and global third-party vendors and product manufacturers. Scilex believes its success will be significantly impacted by its ability to create and maintain a safe inclusive environment where everyone is empowered to do their best work — regardless of race, gender, religion, national origin, sex, sexual orientation, or disability and other characteristics protected by law.Governance to Support Steady Progress: Transparent corporate governance equals accountability and balancing the short-and long-term interests of Scilex’s community of stakeholders, patients, suppliers and employees. “Our strategy focuses on advancing patient health, fostering an inclusive workforce, and reducing negative environmental impact where possible. We are committed to expanding access to non-opioid pain management products. To enable this strategy, our core mission is to provide patients with access to our medication, from raising awareness to obtaining broader public reimbursement and providing co-pay assistance. We are also committed to scientific excellence, and invest in capa...